Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 9—September 2007
Letter

Disseminated Bocavirus Infection after Stem Cell Transplant

Thomas Schenk*, Brigitte Strahm*, Udo Kontny*, Markus Hufnagel*, Dieter Neumann-Haefelin*, and Valeria Falcone*Comments to Author 
Author affiliations: *Freiburg University Medical Center, Freiburg, Germany;

Main Article

Appendix Figure

Timeline of clinical and virologic features posttransplantation. A) Main clinical events and therapeutic measures. B) Human bocavirus (HBoV) DNA load measured by real-time PCR; 1 mL stool suspension corresponds to 20 mg starting material. Nasopharyngeal samples (NPS) also positive for rhinovirus (RV) RNA by multiplex PCR are indicated by arrows. C) Copies of cytomegalovirus (CMV) DNA measured in blood by real-time PCR. NPSC3.1 plasmid (positive control for PCR) was provided by T. Allender.

Appendix Figure. Timeline of clinical and virologic features posttransplantation. A) Main clinical events and therapeutic measures. B) Human bocavirus (HBoV) DNA load measured by real-time PCR; 1 mL stool suspension corresponds to 20 mg starting material. Nasopharyngeal samples (NPS) also positive for rhinovirus (RV) RNA by multiplex PCR are indicated by arrows. C) Copies of cytomegalovirus (CMV) DNA measured in blood by real-time PCR. NPSC3.1 plasmid (positive control for PCR) was provided by T. Allender.

Main Article

Page created: July 01, 2010
Page updated: July 01, 2010
Page reviewed: July 01, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external